These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2197339)

  • 1. A novel chromosomal TEM derivative and alterations in outer membrane proteins together mediate selective ceftazidime resistance in Escherichia coli.
    Weber DA; Sanders CC; Bakken JS; Quinn JP
    J Infect Dis; 1990 Aug; 162(2):460-5. PubMed ID: 2197339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective ceftazidime resistance in Escherichia coli: association with changes in outer membrane protein.
    Bakken JS; Sanders CC; Thomson KS
    J Infect Dis; 1987 Jun; 155(6):1220-5. PubMed ID: 3553348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TEM-4, a new plasmid-mediated beta-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Escherichia coli.
    Paul GC; Gerbaud G; Bure A; Philippon AM; Pangon B; Courvalin P
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1958-63. PubMed ID: 2692515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of a unique ceftazidime-hydrolysing beta-lactamase, TEM-E2.
    Payne DJ; Marriott MS; Amyes SG
    J Med Microbiol; 1990 Jun; 32(2):131-4. PubMed ID: 2192063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefotaxime and ceftazidime-resistant Escherichia coli isolate producing TEM-15 beta-lactamase from a Tunisian hospital.
    Chouchani C; Ben-Achour N; M'charek A; Belhadj O
    C R Biol; 2007 Aug; 330(8):565-70. PubMed ID: 17637436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutants of the TEM-1 beta-lactamase conferring resistance to ceftazidime.
    Payne DJ; Marriott MS; Amyes SG
    J Antimicrob Chemother; 1989 Aug; 24(2):103-10. PubMed ID: 2676935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. False extended-spectrum {beta}-lactamase phenotype in clinical isolates of Escherichia coli associated with increased expression of OXA-1 or TEM-1 penicillinases and loss of porins.
    Beceiro A; Maharjan S; Gaulton T; Doumith M; Soares NC; Dhanji H; Warner M; Doyle M; Hickey M; Downie G; Bou G; Livermore DM; Woodford N
    J Antimicrob Chemother; 2011 Sep; 66(9):2006-10. PubMed ID: 21742679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae.
    Quinn JP; Miyashiro D; Sahm D; Flamm R; Bush K
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1451-6. PubMed ID: 2684007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TEM-E1: a novel beta-lactamase conferring resistance to ceftazidime.
    Payne DJ; Marriott MS; Amyes SG
    FEMS Microbiol Lett; 1989 May; 50(1-2):97-100. PubMed ID: 2661324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically diverse ceftazidime-resistant isolates from a single center: biochemical and genetic characterization of TEM-10 beta-lactamases encoded by different nucleotide sequences.
    Rasmussen BA; Bradford PA; Quinn JP; Wiener J; Weinstein RA; Bush K
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1989-92. PubMed ID: 8239618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel extended-spectrum TEM-type beta-lactamase from an Escherichia coli isolate resistant to ceftazidime and susceptible to cephalothin.
    Chanal-Claris C; Sirot D; Bret L; Chatron P; Labia R; Sirot J
    Antimicrob Agents Chemother; 1997 Mar; 41(3):715-6. PubMed ID: 9056022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmid-mediated beta-lactamase (TEM-7) involved in resistance to ceftazidime and aztreonam.
    Gutmann L; Kitzis MD; Billot-Klein D; Goldstein F; Tran Van Nhieu G; Lu T; Carlet J; Collatz E; Williamson R
    Rev Infect Dis; 1988; 10(4):860-6. PubMed ID: 3055178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and genetic characteristics of TEM-29B, a novel extended spectrum beta-lactamase.
    Bou G; Martínez-Beltrán J; Cerveró G; Pérez-Díaz JC
    FEMS Microbiol Lett; 1999 May; 174(1):185-90. PubMed ID: 10234838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel R-factor borne beta-lactamase of Escherichia coli confering resistance to cephalosporins.
    Bauernfeind A; Hörl G
    Infection; 1987; 15(4):257-9. PubMed ID: 3312022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does high level production of SHV-type penicillinase confer resistance to ceftazidime in Enterobacteriaceae?
    Petit A; Ben Yaghlane-Bouslama H; Sofer L; Labia R
    FEMS Microbiol Lett; 1992 Apr; 71(1):89-94. PubMed ID: 1624115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel extended-spectrum beta-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance.
    Stürenburg E; Kühn A; Mack D; Laufs R
    J Antimicrob Chemother; 2004 Aug; 54(2):406-9. PubMed ID: 15201232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of a transferable SHV-5 type beta-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece.
    Vatopoulos AC; Philippon A; Tzouvelekis LS; Komninou Z; Legakis NJ
    J Antimicrob Chemother; 1990 Nov; 26(5):635-48. PubMed ID: 2079446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression levels of chromosomal AmpC β-lactamase in clinical Escherichia coli isolates and their effect on susceptibility to extended-spectrum cephalosporins.
    Paltansing S; Kraakman M; van Boxtel R; Kors I; Wessels E; Goessens W; Tommassen J; Bernards A
    Microb Drug Resist; 2015 Feb; 21(1):7-16. PubMed ID: 25188329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRC-1: emergence of a clavulanic acid-resistant TEM beta-lactamase in a clinical strain.
    Thomson CJ; Amyes SG
    FEMS Microbiol Lett; 1992 Mar; 70(2):113-7. PubMed ID: 1316862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro selection and characterization of mutants in TEM-1-producing Escherichia coli by ceftazidime and ceftibuten.
    Perilli M; Segatore B; Tavio M; Setacci D; Celenza G; De Santis F; Pellegrini C; Rossolini GM; Amicosante G
    J Chemother; 2007 Apr; 19(2):123-6. PubMed ID: 17434819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.